US BIOLOGIC Delivers Disease Prevention® by providing orally delivered vaccines
to address the world's great health challenges.
US BIOLOGIC Delivers Disease Prevention® by providing orally delivered vaccines to address the world's great health challenges.
US BIOLOGIC is a social innovation company that "Delivers Disease Prevention®”. The company’s proprietary oral-delivery platform is changing global disease prevention, allowing safe, effective, and cost-efficient delivery of a variety of preventative therapeutics (vaccine and antimicrobial) to wildlife, companion animals, food animals, and humans.
US BIOLOGIC works with world-renowned experts, placing their proven technologies into its oral-delivery platform and then commercializes those new products by providing necessary funding, regulatory support, manufacturing, and distribution expertise. Our solutions include tick-borne diseases, pet health, food-animal health, human health, predictive analytics, and rapid pandemic response.
BARDA DRIVe partners with US Biologic, Inc. in the development of an oral vaccine for pandemic influenza
The U.S. DHHS Biomedical Advanced Research and Development Authority (BARDA) Division of Research Innovation and Ventures (DRIVe) is partnering with US Biologic Inc. to advance the development of an oral vaccine for the influenza virus. Read More
"US Biologic envisions a world where everyone has equitable access to lifesaving technologies," stated Mason Kauffman, CEO of US Biologic. "Our mission is to reduce disease through predictive analytics and orally delivered vaccines and therapeutics delivered to the home. Read More
Researchers at the USDA’s Agricultural Research Service and US Biologic, Inc., have developed an oral solution to an antibiotic alternative that fights against poultry coccidiosis. Full article